A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six Months
Erectile Dysfunction
About this trial
This is an interventional treatment trial for Erectile Dysfunction focused on measuring Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy male subjects or males with mild erectile dysfunction (ED). Between the ages of 30 and 65 years, inclusive. Exclusion Criteria: Phosphodiesterase type 5 (PDE5) inhibitor therapy (tadalafil, sildenafil, or vardenafil) within 6 weeks of the start of the study. Diagnosis of diabetes mellitus. Any chronic illness or medication that is a risk factor for eye disease or any medication that causes retinal toxicity or affects visual function. Certain chronic medical conditions including unstable angina pectoris, severe renal [kidney] insufficiency, clinically significant hepatobiliary [liver, bile duct] disease, cancer, and AIDS/HIV. A history of clinically significant chronic ophthalmologic disease or any significant visual abnormality identified at the start of the study.
Sites / Locations
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.